Pembrolizumab in our country and over the ocean

05/2019

Prof. MUDr. Jindřich Fínek, Ph.D., MHA

Onkologická a radioterapeutická klinika LF UK a FN Plzeň

SUMMARY

Pembrolizumab is a humanized monoclonal antibody against programmed cell death 1 receptors (PD-1) (an IgG4/K isotype with a stabilizing sequence change in the Fc region) produced by recombinant DNA technology in Chinese hamster ovary cells.

Key words

pembrolizumab, a humanized monoclonal antibody, programmed cell death 1